Search Medical Condition
Please enter condition
Please choose location

Skin Infections/Disorders Clinical Trials

A listing of Skin Infections/Disorders medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (15) clinical trials

This study is testing an investigational medication for Atopic Dermatitis.

Phase N/A

Please consider this clinical research study your colleagues are conducting. A clinical research study for skin and skin structure infections is enrolling now. This study is a double-blind, multicenter, randomized, Phase 3 study comparing an investigational antibiotic versus linezolid for the treatment of adults with ABSSSI. This study is enrolling ...

Phase N/A

The purpose of this study is to test the safety, tolerability and efficacy of the drug, iclaprim. It will be compared to vancomycin for the treatment of bacterial skin infections caused by bacteria called Gram-positive bacteria. Both these drugs are antibiotics (drugs that kill bacteria). Iclaprim is an experimental drug, ...

Phase N/A

Volunteers with neutrophilic skin disease are needed to participate in a research study to assess the safety, tolerability, and activity of an investigational drug that is being developed as a potential treatment for plaque psoriasis, palmoplantar pustulosis, or hidradenitis suppurativa. Eligible participants will be men and women diagnosed with one ...

Phase

Qualified participants will receive at no cost to them: study medications study-related labs physicals and exams compensation for your time and travel for each visit

Phase N/A

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

Background: - Multicentric Castleman's disease (MCD) is a rare but lethal Kaposi's sarcoma-associated herpesvirus (KSHV) associated lymphoproliferative disorder with a median survival of 2 years. It occurs more often in HIV-infected individuals than those without HIV infection. The poor prognosis is not fully explained by the underlying HIV, as the ...

Phase

Infections Caused by ESbL-Producing Enterobacteriaceae in Italy

RESEARCH PLAN AND METHODOLOGY Population All patients with infections (i.e. bacteremia, pneumonia, abdomen infections, skin infections, and urinary tract infections) caused by ESBL-producing Enterobacteriaceae. Exclusion criteria Children < 16 years Trial design Multicenter prospective cohort study. Patients corresponding to the study definition will be detected by daily inspection of microbiological ...

Phase N/A

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children Known or Suspected to be Caused by Susceptible Gram-positive Organisms Including MRSA

To determine the safety and descriptive efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections in children, aged 3 months to 17 years, known or suspected to be caused by susceptible Gram-positive organisms, including methicillin-resistant strains of Staphylococcus aureus.

Phase